From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
MCT1
MCT4
MCT2
n
Positive (%)
p
CD147
< 0.001
0.184
Negative
59
20.3
84
26.7
35
40.0
Positive
107
64.5
83
63.0
131
50.4